Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs and Procurement
- NARA ID
- review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Source
- oig-doj
- Collection
- DOJ OIG — Federal Bureau of Prisons
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2020-02-20
- Slug
- doj-oig-review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Indexed
- 2026-04-27 05:04:10
More from DOJ OIG — Federal Bureau of Prisons
- Audit of the Federal Bureau of Prisons Annual Financial Statements Fiscal Year 2016
- Remote Inspection of Federal Correctional Institution Milan
- Audit of the Federal Bureau of Prisons Annual Financial Statements Fiscal Year 2013
- Remote Inspection of Federal Correctional Complex Lompoc
- Investigative Summary: Findings of Misconduct by a BOP Executive Assistant Who Engaged in an Inappropriate Relationship With a BOP Contractor Who Had Been a Federal Inmate, Failed to Cooperate in Our Investigation, Destroyed Evidence, & Related Misconduct
- Audit of the Federal Bureau of Prisons’ Oversight of the Use of Restraints
Browse all 151 documents in DOJ OIG — Federal Bureau of Prisons →
About the DOJ OIG — Federal Bureau of Prisons collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Federal Bureau of Prisons.